CD8A and neoplasm: Interestingly, when treatments with the β-AR agonist isoprenaline were administered daily to mimic chronic stress conditions, the capability of CD8+ T cells to directly kill tumour cells was impaired, along with their ability to produce interferon-gamma (IFN-γ) (Nissen 2018).